The homodimeric aspartyl protease HIV protease, which cleaves proviral polyproteins to produce mature protein components necessary for the development of an infectious virus, is essential for the viral life cycle. In order to create the mature protein components of an infectious HIV virion, HIV protease cleaves newly synthesized polyproteins at the proper locations. When developing anti-retroviral medications to treat HIV/AIDS (acquired immune deficiency syndrome), HIV protease is a crucial drug target.
HIV-1 protease breaks down the polyproteins Gag and Gag-Pro-Pol to allow viral maturation. More than 12 different substrates are recognized and broken down, which causes viral maturation. Similar to HIV-1, HIV-2 protease is a homodimeric aspartyl enzyme that plays a crucial part in the HIV life cycle by processing the precursor polyproteins Gag and Gag-Pro-Pol, which results in viral maturation.
| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V116284 | AG-1284 | 162054-18-4 | AG-1284 is an HIV protease inhibitor with an EC50 value of 0.5 mg/mL. |
|
V103134 | Desthiazolylmethyl ritonavir | 256328-82-2 | Desthiazolylmethylritonavir is a base-catalyzed degradation product of the HIV protease inhibitor ritonavir. |
|
V115910 | DMP-851 | 188978-02-1 | DMP-851 is a cyclic urea-based HIV protease inhibitor with a Ki value of 0.021 nM. |
|
V99711 | Elunonavir | 2242428-57-3 | Elunavir (GS-1156) is an HIV protease inhibitor with a high barrier to resistance and excellent metabolic stability. |
|
V136937 | GRL-07524 | GRL-07524 is a potent HIV-1 protease inhibitor (Ki = 0.22 nM). | |
|
V88269 | GS-9770 | 2306328-43-6 | GS-9770 is an orally available HIV protease inhibitor with a Ki of 0.16 nM. |
|
V79791 | HIV Protease Substrate 1 TFA | HIV Protease Substrate 1 TFA is an exogenous HIV protease substrate that may be utilized to study the enzymatic activity of HIV protease. | |
|
V119248 | HIV-1 Protease | HIV-1 protease is synthesized as part of a large Gag-Pol precursor protein. | |
|
V83408 | HIV-1 protease-IN-13 | ||
|
V137392 | HIV-1 protease-IN-14 | HIV-1 protease-IN-14 is a potent HIV-1 protease inhibitor with Ki values of 0.28 nM for wild-type HIV-1 protease and 56.9 nM for R41T mutant HIV-1 protease. | |
|
V79794 | HIV-1 protease-IN-3 | HIV-1 protease-IN-3 (compound 14) is a potent HIV-1 protease inhibitor (IC50=71 nM; EC50=0.86 μM). | |
|
V114750 | HIV-1-IN-88 | 2459707-59-4 | V-1-IN-88 (compound 20a) is a potent HIV-1 protease inhibitor (IC50 = 10 pM) with an antiviral EC50 value of 10.4 nM. |
|
V112145 | HIV-1-IN-91 | HIV-1-IN-91 (compound BAN) is an HIV-1 protease inhibitor. | |
|
V137676 | Hydroxy darunavir | 1130635-75-4 | Hydroxy darunavir is a metabolite of darunavir, an HIV-1 protease inhibitor. |
|
V88270 | Longipedunin A | 886441-72-1 | Longipedunin A is a HIV-1 protease inhibitor with an IC50 value of 50 µg/mL. |
|
V88273 | NNRT-IN-3 | NNRT-IN-3 (Compound 8) is a HIV-1 non-nucleoside reverse transcriptase (NNRT) inhibitor (EC50=0.01 μM). | |
|
V80960 | NNRTIs-IN-3 | NNRTIs-IN-3 (compound 8) is an HIV-1 non-nucleoside reverse transcriptase inhibitor (EC50=0.01 µM). | |
|
V110365 | PAC-Phe-Val | 3088543-72-7 | PAC-Phe-Val is a potent HIV-1 protease inhibitor with an IC50 value of 33.10 nM. |
|
V88271 | RK-682 | 150627-37-5 | RK-682 is an inhibitor of protein tyrosine phosphatase (PTPase), heparinase, phospholipase A2 and HIV-1 protease. |
|
V88272 | RK-682 hemicalcium | 332131-32-5 | RK-682 hemicalcium is the calcium salt form of RK-682. |